APPARATUS AND METHOD FOR ELECTROMAGNETIC TREATMENT
Described herein are electromagnetic treatment devices for treatment of tissue. In particular, described herein are lightweight, wearable, low-energy variations that are specifically configured to specifically and sufficiently apply energy within a specific bandpass of frequencies of a target biological pathway, such as the binding of Calcium to Calmodulin, and thereby regulate the pathway. Methods and systems for treating biological tissue are also described.
1 . A low-power, and lightweight electromagnetic treatment device for treating a target tissue by stimulation of a target pathway structure, the device comprising:
a lightweight applicator comprising a flexible wire loop that is bendable to conform to a target anatomy, wherein the applicator is configured to deliver an electromagnetic signal to a target tissue; and
a control circuit including a micro-controller configured to control the burst duration, the burst period, and the duration of a single treatment application, wherein the micro-controller is configured to apply broad spectral density bursts of electromagnetic waveforms to achieve maximal signal power within a bandpass of a biological target; and
wherein the control circuit further comprises a pulse phase timing control configured to regulate the burst duration and burst period and configured to provide a signal to the applicator to induce an electric field of amplitude of between about 1 μV/cm to about 100 mV/cm at the target tissue and a peak induced magnetic field between about 1 μT and about 20 μT, wherein the control circuit generates a burst of waveforms having a burst duration of greater than 0.5 msec and a burst period of between about 0.1 to about 10 seconds to produce a signal that is above background electrical activity in the target tissue.
2 . The device of claim 1 , wherein the device is wearable.
3 . The device of claim 1 , wherein the control circuit is configured to generate an electromagnetic signal to modulate calcium binding to calmodulin in the target pathway structure.
4 . The device of claim 1 , wherein the device is implantable.
5 . The device of claim 1 , wherein the device is disposable.
6 . The device of claim 1 , wherein the control circuit is configured to generate a signal to modulate the production and utilization of growth factors, cytokines, and regulatory substances by living cells.
7 . The device of claim 6 , wherein the growth factors include at least one of fibroblast growth factors, platelet derived growth factors and interleukin growth factors.
8 . The device of claim 1 , wherein the waveforms generated by the control circuit have a frequency of approximately 27.12 MHz.
9 . The device of claim 1 further comprising a therapeutic device for positioning said applicator in proximity to a target pathway structure.
10 . The device of claim 9 , wherein the therapeutic device includes at least one of an anatomical support, an anatomical wrap, apparel, a mattress, a mattress pad, a wheelchair, a therapeutic chair, a therapeutic bed, and sporting goods.
11 . The device of claim 1 , wherein the signal provided to the applicator is configured to capacitively couple to living cells and tissues to modulate angiogenesis and neovascularization for the treatment of cardiovascular diseases.
12 . The device of claim 1 , wherein the signal provided to the applicator by the control circuit is configured to inductively couple to living cells and tissues to modulate angiogenesis and neovascularization for the treatment of cardiovascular diseases.
13 . The device of claim 1 , wherein the signal provided to the applicator by the control circuit is inductively coupled to living cells and tissues to modulate angiogenesis and neovascularization for the treatment of cerebral diseases.
14 . The device of claim 1 , wherein the signal provided to the applicator by the control circuit is capacitively coupled to living cells and tissues to modulate angiogenesis and neovascularization for the treatment of cerebral diseases.
15 . The device of claim 1 , wherein the signal provided to the applicator by the control circuit is inductively coupled to living cells and tissues to modulate angiogenesis and neovascularization for the treatment of cerebrovascular disease.
16 . The device of claim 1 , wherein the signal provided to the applicator by the control circuit is capacitively coupled to living cells and tissues to modulate angiogenesis and neovascularization for the treatment of cerebrovascular disease.
17 . The device of claim 1 , further comprising a delivery means for standard physical therapy modalities.
18 . The device of claim 17 , wherein said standard physical therapy modalities includes heat, cold, massage, and exercise.
19 . The device of claim 1 , wherein the background electrical activity is baseline thermal fluctuations in voltage and electrical impedance at the target pathway structure.
20 . The device of claim 1 , further comprising a chest garment, wherein the device is incorporated into the chest garment.
21 . The device of claim 1 , wherein the applicator comprises at least one of an inductive coupling means and a capacitive coupling means, connected to the micro-controller for delivering an electromagnetic signal to a fibrous capsule formation and capsular contracture target pathway structure.
22 . The device of claim 1 , wherein the signal generated by the control circuit comprises a signal to noise ratio or power signal to noise ratio of at least about 0.2 to modulate ion and ligand interactions in a fibrous capsule formation and capsular contracture target pathway structure above baseline thermal fluctuations in voltage and electrical impedance at the fibrous capsule formation and capsular contracture target pathway structure.